Kymera Therapeutics, Inc.

Fintech firm providing data analytics and market intelligence for investment professionals.

KYMR | NDAQ

Overview

Corporate Details

ISIN(s):: US5015751044
LEI:
Country:: United States of America
Address:: 500 NORTH BEACON STREET, 4TH FLOOR, 2472 WATERTOWN
Website:: https://www.kymeratx.com/
Sector:: Mining and quarrying
Industry:: Mining of non-ferrous metal ores

Description

Kymera Therapeutics, Inc. is a revolutionary financial technology firm redefining investment paradigms through targeted data analytics. Leveraging its powerful and highly productive data discovery engine, the company delivers a pipeline of first-in-class analytics and market intelligence solutions for financial institutions and investment professionals. Kymera's platform provides a market-agnostic modality for discovering alpha and managing risk, fundamentally changing how clients access and utilize data. The firm is committed to delivering transformative insights with precision, focus, and a sense of urgency to a global client base.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
	2025-11-04 13:15	Quarterly Report 10-Q - Kymera Therapeutics, Inc. (0001815442) (Filer)	English	2.2 MB
	2025-11-04 13:10	Regulatory News Service 8-K - Kymera Therapeutics, Inc. (0001815442) (Filer)	English	225.9 KB

Automate Your Workflow. Get a real-time feed of all Kymera Therapeutics, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Kymera Therapeutics, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for Kymera Therapeutics, Inc. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
NFL Biosciences Develops botanical drug candidates to treat smoking and alcohol addictions.	France	ALNFL
NGS Group Nordic staffing & recruitment for healthcare, education, and social services sectors.	Sweden	NGS
Nihon M&A Center Holdings Inc. M&A advisory firm specializing in brokerage and consulting for Japanese SMEs, including cross-border deals.	Japan	2127
Noile-Immune Biotech Inc. Developing PRIME technology-enhanced CAR-T cell immunotherapies for treating solid tumors.	Japan	4893
NRGene Technologies Ltd. AI-powered genomic analysis software to accelerate and optimize plant and animal breeding.	Israel	NRGN
Nuvectis Pharma, Inc. Clinical-stage biopharma developing precision medicines for serious oncological conditions.	United States of America	NVCT
Nykode Therapeutics ASA Developing novel immunotherapies and vaccines for cancer with its antigen-targeting platform.	Norway	NYKD
Ocugen, Inc. Develops gene/cell therapies and vaccines, specializing in blindness and public health.	United States of America	OCGN
Oculis Holding AG Clinical-stage biopharma developing non-invasive eye drops for sight-threatening diseases.	Switzerland	OCS
OKYO Pharma Ltd Biopharma developing novel drugs for inflammatory eye diseases and neuropathic corneal pain.	United States of America	OKYO